Effects of orally active hypoxia inducible factor alpha prolyl hydroxylase inhibitor, FG4592 on renal fibrogenic potential in mouse unilateral ureteral obstruction model

Orally active hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors that stabilize HIF protein and stimulate the production of erythropoietin have been approved to treat renal anemia. Our previous report suggested that HIF-1α dependent fibrogenic mechanisms are operating at the early onset of...

Full description

Saved in:
Bibliographic Details
Main Authors: Kazuya Kabei (Author), Yu Tateishi (Author), Masayuki Shiota (Author), Mayuko Osada-Oka (Author), Shunji Nishide (Author), Junji Uchida (Author), Tatsuya Nakatani (Author), Shinji Matsunaga (Author), Takehiro Yamaguchi (Author), Shuhei Tomita (Author), Katsuyuki Miura (Author)
Format: Book
Published: Elsevier, 2020-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available